No recent analyst price targets found for RAAS.
Latest News for RAAS
Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings
[url="]Alnylam Pharmaceuticals, Inc[/url]. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for RAAS.
Senate Trading
No Senate trades found for RAAS.
U.S. House Trading
No House trades found for RAAS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.